Skip to content
zameds

Enrofloxacin (Baytril)

Enrofloxacin

Elanco Animal Health (Pty) Ltd

S4

Registration

Applicant
Elanco Animal Health (Pty) Ltd
Registrations
6
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Baytril 100

EACH 100,0 ml SOLUTION CONTAINS: ENROFLOXACIN 10,0 g

10002/0602/21.9/6RegisteredS4None
Baytril

EACH 1 ml SOLUTION CONTAINS ENROFLOXACIN 100 mg

Not listed87/687/21.9/6CancelledS4None
Baytril 15 MG tablets

EACH TABLET CONTAINS ENROFLOXACIN 15 mg

15 mgTablets88/1088/21.9/10RegisteredS4None
Baytril 50 MG tablets

EACH TABLET CONTAINS ENROFLOXACIN 50 mg

50 mgTablets88/1188/21.9/11RegisteredS4None
Baytril 150 MG tablets

EACH TABLET CONTAINS ENROFLOXACIN 150 mg

150 mgTablets88/1288/21.9/12RegisteredS4None
Baytril 5 %

EACH 1 ml SOLUTION CONTAINS ENROFLOXACIN 50 mg

5 %88/888/21.9/8RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Enrofloxacin

  • S4: Enrofloxacin

    Consolidated Schedules 06 July 2026, line 6191

Pharmacological class: Androgen-oestrogen combinations. (class 21.9)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C19H22FN3O3359.40 g/mol

1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid

Drag to rotate. Structure from PubChem CID 71188.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles